Translational Development Acquisition Income Statement (2023-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2023	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating items
Selling, General & Administrative (Quarter)		0.06M	0.13M	0.35M	0.22M	0.21M	0.16M	0.28M
Other Operating Expenses (Quarter)	0.49M
Operating Expenses (Quarter)	0.49M	0.06M	0.13M	0.35M	0.22M	0.21M	0.16M	0.28M
Operating Income (Quarter)		-0.06M	-0.13M	-0.35M	-0.22M	-0.21M	-0.16M	-0.28M
EBIT (Quarter)		-0.06M	-0.13M	-0.35M	-0.22M	-0.21M	-0.16M	-0.28M
Non-operating items
Non Operating Investment Income (Quarter)			0.13M
Other Non Operating Income (Quarter)			0.13M	1.83M	1.84M	1.87M	1.63M	1.61M
Non Operating Income (Quarter)			0.13M	1.83M	1.84M	1.87M	1.76M	1.61M
Net income details
EBT (Quarter)		-0.06M	-0.13M	-0.35M	-0.22M	-0.21M	-0.16M	-0.28M
Profit After Tax (Quarter)		-0.06M	-0.01M	1.48M	1.62M	1.66M	1.60M	1.33M
Income from Continuing Operations (Quarter)		-0.06M	-0.13M	-0.35M	-0.22M	-0.21M	-0.16M	-0.28M
Consolidated Net Income (Quarter)		-0.06M	-0.13M	-0.35M	-0.22M	-0.21M	-0.16M	-0.28M
Income towards Parent Company (Quarter)		-0.06M	-0.13M	-0.35M	-0.22M	-0.21M	-0.16M	-0.28M
Net Income towards Common Stockholders (Quarter)		-0.06M	0.06M	1.17M	1.28M	1.31M	-2.40M	0.28M
Additional items
EPS (Basic) (Quarter)		-0.02	0.01	0.07	0.07	0.08	-0.14	0.02
EPS (Diluted) (Quarter)		-0.02	0.01	0.07	0.07	0.08	-0.14	0.02
Shares Outstanding (Quarter)	4.05M	4.05M	4.06M	17.25M	17.25M	17.25M	17.25M	17.25M
Shares Outstanding (Diluted) (Quarter)	4.05M	4.05M	4.66M	17.25M	17.25M	17.25M	17.25M	17.25M
Shares Outstanding (Entity) (Quarter)	4.66M	4.66M	4.66M	17.25M	17.25M	17.25M	17.25M	17.25M
EBITDA (Quarter)		-0.06M	-0.13M	-0.35M	-0.22M	-0.21M	-0.16M	-0.28M

Translational Development Acquisition TDACU Income Statement (2023-2026)